Low dose interferon-alpha is safe in patients with myasthenia gravis.
AUTOR(ES)
Bolay, H
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1064180Documentos Relacionados
- Myasthenia gravis in a patient with chronic active hepatitis C during interferon-alpha treatment.
- Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis.
- Interferon-alpha receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-alpha therapy of patients with chronic hepatitis C
- Treating patients with myasthenia gravis.
- Absence of immunoreactive interferon-alpha in CSF from patients with multiple sclerosis.